Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Many people with hair loss experience scalp pain known as trichodynia, but the causes are unclear and treatments vary.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Tailored nonsurgical cosmetic procedures are crucial for safely treating diverse skin types, especially skin of color.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Most hospitalized internal medicine patients have undiagnosed skin problems and want them treated.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Understanding and treating hair disorders in different ethnic groups requires knowledge of specific hair care practices and hair characteristics.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Combination therapies might work better for some vitiligo patients, but results vary.